Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) (TRAIL-RCT)

June 19, 2023 updated by: Brodie Sakakibara, University of British Columbia

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT): A Randomized Controlled Trial

The purpose of this study is to compare the effectiveness of a 4-week lower extremity telerehabilitation protocol with aims to improve lower extremity function to a 4-week attention-controlled education program on lower extremity clinical outcomes, quality of life, and healthcare resources utilization among community dwelling adults with stroke across Canada.

Study Overview

Detailed Description

With an aging population, and survival rates now at 83% in Canada, the number of stroke survivors is expected to reach 720,000 by 2038. While 90% of individuals with stroke return to independent community living, 80% report residual motor impairment, such as loss or limitation in motor control, or mobility limitation. These limitations have profound effects on the ability to perform everyday activities and are associated with substantial economic strain on the healthcare system. Thus, a primary focus of stroke rehabilitation is on the recovery of motor function, walking and balance, using exercise via physical therapy.

The rapid growth in Internet use and personal mobile devices has opened an array of possibilities for stroke survivors to remotely access specialized rehabilitation from their homes and communities (i.e., telerehabilitation). Telerehabilitation interventions have been used effectively for check-in sessions, education, and counselling after stroke, but knowledge of the effectiveness of using telerehabilitation for the delivery of exercise interventions for lower extremity recovery is limited.

The investigators developed the TeleRehabilitation with Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL) to address the unmet needs for lower extremity rehabilitation after stroke, and the need for accessible rehabilitation in the face of the COVID-19 pandemic. TRAIL is an exercise program designed to promote lower extremity recovery using technology with real-time therapist instruction and guidance. The investigators recently conducted a proof-of-concept, single-group feasibility study of TRAIL (TRAIL-PROOF). From TRAIL-PROOF, there were have no reports of serious adverse events and 100% retention of participants. Preliminary analysis of 32 individuals completed also suggest improvements in the clinical outcomes, including increased lower extremity strength, functional balance, and balance self-efficacy. Thus, from TRAIL-PROOF, it is evident that the TRAIL protocol has potential to improve lower extremity function among community-dwelling adults with stroke experiencing lower extremity impairment. The investigators now propose a full-scaled randomized controlled trial to further study the TRAIL program (TRAIL-RCT).

The objectives for TRAIL-RCT are as follows:

  1. The primary objective is to compare functional mobility (Timed Up and Go, primary clinical outcome) after 4 weeks of TRAIL to a 4-week attention-controlled education program (EDUCATION) in individuals ≤12 months post-stroke;
  2. The secondary objective is to compare the 4-week TRAIL and EDUCATION programs on secondary outcomes of:

    1. Lower extremity strength (30-Second Sit-to Stand test);
    2. Functional balance (Tandem Stand and Functional Reach);
    3. Motor impairment (Virtual Fugl-Meyer Assessment);
    4. Balance self-efficacy (Activities-specific Balance Confidence Scale);
  3. The tertiary objective is to compare the 4-week TRAIL and EDUCATION programs on health economic outcomes:

    1. Health-related quality of life (Stroke Impact Scale, EuroQol-5D-5 Level); and
    2. Health resources and costs (Health Resource Utilization Questionnaire)
  4. The quaternary objective is to evaluate the feasibility of a subsequent larger multisite implementation stepped wedge randomized trial of TRAIL using pre-specified criteria related to process, resources, management, and scientific indicators.

It is hypothesized that:

The primary hypothesis is that the 4-week TRAIL program will lead to greater improvement in functional mobility, as measured by the Timed Up and Go, compared to the 4-week EDUCATION program in individuals ≤12 months post-stroke (Objective 1, primary clinical outcome).

The investigators also anticipate that greater improvements will be observed in the secondary clinical outcomes, in the areas of lower extremity muscle strength, motor impairment, functional balance, and balance self-efficacy, following TRAIL compared to EDUCATION (Objective 2).

The tertiary hypothesis is that the TRAIL intervention will demonstrate superior health economic outcomes compared to the EDUCATION group (Objective 3).

The quaternary hypothesis is that the protocol will demonstrate sufficient feasibility (e.g., rates of recruitment/retention, treatment fidelity and adherence, safety, treatment effects) to support a subsequent larger multi-site implementation stepped wedge randomized controlled trial (Objective 4).

Study Type

Interventional

Enrollment (Estimated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V6T 1Z4
        • Recruiting
        • University of British Columbia
        • Contact:
        • Contact:
        • Principal Investigator:
          • Brodie Sakakibara, PhD
        • Principal Investigator:
          • Janice Eng, PT/OT PhD
        • Principal Investigator:
          • Courtney Pollock, PT PhD
    • Halifax
      • Nova Scotia, Halifax, Canada, B3H 4R2
        • Recruiting
        • Dalhousie University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Marilyn MacKay-Lyons, MScPT PhD
    • Manitoba
      • Winnipeg, Manitoba, Canada, R3L 2P4
        • Recruiting
        • Riverview Health Centre
        • Contact:
        • Contact:
        • Principal Investigator:
          • Ruth Barclay, PhD
        • Principal Investigator:
          • Sepideh Pooyania, MD FRCPC
    • Ontario
      • London, Ontario, Canada, N6C 5J1
      • Toronto, Ontario, Canada, M5G 2C4
        • Recruiting
        • University Health Network
        • Contact:
        • Principal Investigator:
          • Mark Bayley, MD FRCPC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ≥19 years of age, ≤12 months post-stroke with lower extremity hemiparesis
  • Able to walk ≥10 meters with or without a gait aid and without physical assistance of another person
  • Can tolerate 50 minutes of activity (including rest breaks)
  • Has cognitive-communicative ability to participate, per clinical judgement
  • Able to provide consent
  • Has a caregiver, friend, or family member available to provide physical support during the assessment sessions

Exclusion Criteria:

  • Currently participating in formal in- or out-patient stroke rehabilitation focusing on lower extremity training
  • Living in long-term care
  • Severe vision or hearing loss
  • Significant musculoskeletal or other neurological conditions
  • Not medically stable
  • Comorbidities (e.g. limb amputation), pain or other symptoms that significantly impact lower extremity function
  • Planned surgery that would preclude or affect participation in the protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TRAIL
TRAIL is a 4-week progressive exercise and self-management intervention for lower extremity recovery delivered by a trained registered physical therapist, in a 2:1 participant-to-therapist ratio. Each participant grouping will receive two telerehabilitation sessions (60-90 minutes) each week for 4 weeks (total 8-12 hours).

Each week has a specific focus for lower extremity rehabilitation:

Week 1) Building a base: 8 exercises, 10-15 repetitions x 2-3 sets

Week 2) Increasing repetitions: 8 exercises, 15-20 repetitions x 3 sets

Week 3) Building exercise tolerance:10 exercises, 15-20 repetitions x 3 sets

Week 4) Maximizing repetitions: 10 exercises, 30 seconds as many reps as possible x 2 sets

At the end of the second exercise session each week, the therapist and participants work collaboratively to develop an independent exercise action plan to be completed before the first session of the next week. The self-managed plans includes exercises selected from TRAIL, agreed upon by the participant and therapist, that are safe to perform without therapist oversight. The aims of the exercise action plan are to: i) Add exercise volume without using program resources (e.g., therapist time); and ii) Build capacity for self-management for long-term health and well-being after TRAIL has ended.

Active Comparator: EDUCATION

The EDUCATION control arm is a 4-week education program focusing on stroke knowledge and risk factors. It will be delivered by health professionals who have experience working with individuals with stroke, knowledge of chronic disease self-management (e.g. physical or occupational therapists, nurses, kinesiologists), and who have completed study-specific training on the EDUCATION program

Participants will receive video conferencing sessions with the same schedule and 2:1 participant-to-coach ratio as TRAIL. Each participant grouping will receive two educational telerehabilitation sessions (60-90 minutes) each week for 4 weeks (total 8-12 hours).

EDUCATION has a specific focus on:

Week 1) What is stroke (e.g., gaining an understanding of the function of the brain, types of stroke and how stroke affects physical function) and introduction to self-management;

Week 2) What is self-management;

Week 3) Self-management for post-stroke complications (e.g., activities of daily living);

Week 4) Self-management for secondary prevention (e.g., blood pressure, diet, medication, stress management).

Education therapists will be provided with lesson plans and manuals to be circulated with the participants, and will facilitate the educational session through interactive Powerpoint presentations. In addition, participants will be asked to complete 30-60 minutes of educational homework, which will be discussed at the commencement of the following session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Timed Up and Go (TUG) at 4 weeks
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Performance walking test to assess functional mobility
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroke Impact Scale (SIS)
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Stroke specific, self-reported health status measure. There are 8 domains assessed in this version and each item is rated using a 5-point Likert scale. The participant rates his/her difficulty completing the task from 1 to 5, where lower scores mean greater difficulty to complete the item.
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Activities-Specific Balance (ABC) Scale
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Self-reported questionnaire measuring self-efficacy in performing activities without losing balance. The ABC Scale consists of 16 questions that require the participant to rate their confidence in performing the activity from 0% to 100%, where higher percentages indicate greater self-efficacy
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Functional Reach
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Performance measure to assess balance through maximal forward reach (in cm) from a fixed base
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Modified Virtual Fugl-Meyer Assessment
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Performance measure to assess lower extremity impairment
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
30 second Sit to Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Performance measure used to assess lower extremity strength
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Health Resource Utilization Questionnaire
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Health care utilization calculated by assessing health professional visits, admissions to hospital, laboratory tests/ investigations, and use of medications
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Health-related quality of life (EuroQol-5D-5 Level)
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
A generic preference-based utility instrument composed of 5 domains of health (mobility, self-care, usual activities, pain, anxiety/depression), each with 5 levels (1=no problems, 5=major problems), which is often used to calculate cost-utility
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Tandem Stand
Time Frame: Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months
Performance measure to assess balance through holding a tandem stance position (up to 10 seconds; alternate positions: semi-tandem or feet together
Baseline, Post-Intervention (immediately following 4 weeks of intervention), 3-months, 6-months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility Indicator: Recruitment Rate
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Number of participants recruited
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Retention Rate
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Number of participants with post-intervention data
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Perceived Benefit of Telerehabilitation
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
Satisfaction survey administered at the end of post-intervention visit
Post-Intervention (immediately following 4 weeks of intervention)
Feasibility Indicator: Treatment Fidelity
Time Frame: Post-Intervention (immediately following 4 weeks of intervention)
Percentage of telerehabilitation sessions attended, exercise completed during telerehabilitation sessions, and self-management sessions completed
Post-Intervention (immediately following 4 weeks of intervention)
Feasibility Indicator: Blinding of Outcome Assessors
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Percentage of outcome assessors remaining blinded to group allocation throughout duration of study
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Appropriateness of Randomization Process
Time Frame: Study Completion (Post-Intervention, immediately following study completion)

Number of participants per group and baseline differences in outcomes between groups

Baseline differences between groups

Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Number of Participants Excluded based on Eligibility Criteria
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Number of individuals excluded from potential participant list (referrals from inpatient stroke rehabilitation and community outreach)
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Participant and Assessor Burden
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Duration (measured in minutes) to complete the assessments.
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Participant Burden
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Percentages of participants with pre- and post-assessments
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Ease of Using Equipment
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Downtime due to technical issues of tablet and video-conferencing platform (measured in minutes)
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Safety
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Number of adverse events from the program sessions or assessments
Study Completion (Post-Intervention, immediately following study completion)
Feasibility Indicator: Processing Time
Time Frame: Study Completion (Post-Intervention, immediately following study completion)
Time from initial contact to enrolment
Study Completion (Post-Intervention, immediately following study completion)
GENESIS-PRAXY Questionnaire
Time Frame: Baseline Assessment
Questionnaire used to assess gender-related measures encompassing gender roles, relations and identity. A composite score is calculated to determine whether an individual has primarily masculine, neutral or feminine gender characteristics.
Baseline Assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Brodie Sakakibara, PhD, University of British Columbia
  • Principal Investigator: Ada Tang, PhD, McMaster University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2021

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

August 1, 2024

Study Registration Dates

First Submitted

May 20, 2021

First Submitted That Met QC Criteria

May 25, 2021

First Posted (Actual)

June 1, 2021

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 19, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The anonymized data collected during the study, the trial protocol, statistical analysis plan, and informed consent form will be shared with qualified researchers engaging in independent scientific research, upon request to the research team.

IPD Sharing Time Frame

After the study end.

IPD Sharing Access Criteria

Please contact the research team.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infarction

Clinical Trials on TRAIL

Subscribe